Regulation of mevalonate metabolism in cancer and immune cells. 2013

Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
Department of Urology, Innsbruck Medical University, Austria. martin.thurnher@i-med.ac.at

The mevalonate pathway is a highly conserved metabolic cascade and provides isoprenoid building blocks for the biosynthesis of vital cellular products such as cholesterol or prenyl pyrophosphates that serve as substrates for the posttranslational prenylation of numerous proteins. The pathway, which is frequently hyperactive in cancer cells, is considered an important target in cancer therapy, since prenylated members of the Ras superfamily are crucially involved in the control of proliferation, survival, invasion and metastasis of tumour cells. Upstream accumulation and downstream depletion of mevalonate pathway intermediates as induced for instance by aminobisphosphonates translate into different effects in cancer and immune cells. Thus, mevalonate pathway regulation can affect tumour biology either directly or exhibit indirect antitumour effects through stimulating cancer immune surveillance. The present review summarizes major effects of pharmacologic mevalonate pathway regulation in cancer and immune cells that may collaboratively contribute to the efficacy of cancer therapy.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008798 Mevalonic Acid A dihydroxy monocarboxylic acid and precursor in the biosynthetic pathway known as the mevalonate pathway, which produces terpenes and steroids that are vital for diverse cellular functions. Mevalonate,Acid, Mevalonic
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
August 1997, Cancer research,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
May 2015, Cancer genetics,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
August 2025, FEBS letters,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
September 2022, Journal of cellular physiology,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
September 2020, Nature reviews. Cancer,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
February 2021, Cancers,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
May 2015, Nihon rinsho. Japanese journal of clinical medicine,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
August 2022, Seminars in cancer biology,
Martin Thurnher, and Georg Gruenbacher, and Oliver Nussbaumer
July 2012, Stem cells (Dayton, Ohio),
Copied contents to your clipboard!